MRNA vs RVMD
Moderna and Revolution Medicines, Inc., both Healthcare
Revolution Medicines, Inc. is the larger company at $38B against $25B. Over the past year RVMD returned +336% against +93% for MRNA. The RyuScore puts MRNA ahead, 48 against 7 out of 100.
| Figure | MRNA | RVMD |
|---|---|---|
| Last close | $62.96 | $190 |
| Market cap | $25B | $38B |
| 1-year return | +93% | +336% |
| 5-year return | -81% | +542% |
| RyuScoresector-relative, 1–10 | 48/100 | 7/100 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Moderna
Revenue of $145M in Q2 2026, net income null. Its largest reported line is COVID19, 63% of the disclosed total.
Revolution Medicines, Inc.
Open these two in the interactive comparison to add more names, change the period or see the correlation.